Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 24, 2025 16:30 ET | Source: Onco360 Oncology Pharmacy

Onco360® Has Been Selected as The National Specialty Pharmacy Partner for HYRNUO® (sevabertinib)

LOUISVILLE, Ky., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Bayer Pharmaceuticals for...
November 17, 2025 16:30 ET | Source: Onco360 Oncology Pharmacy

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)

LOUISVILLE, Ky. , Nov. 17, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Kura Oncology for Komzifti™...
October 20, 2025 16:30 ET | Source: Onco360 Oncology Pharmacy

Onco360® Has Been Selected as a Specialty Pharmacy Partner for PHYRAGO™ (dasatinib)

LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Cycle Pharmaceuticals Ltd. for...
June 16, 2025 07:30 ET | Source: Onco360 Oncology Pharmacy

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for IBTROZI™ (taletrectinib), Manufactured by Nuvation Bio Inc.

LOUISVILLE, Ky., June 16, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Nuvation Bio Inc. for...
April 08, 2024 16:35 ET | Source: Onco360 Oncology Pharmacy

Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)

LOUISVILLE, Ky., April 08, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Alexion Pharmaceuticals for...